Versican expression is an adverse prognostic factor in MLL-rearranged infant acute lymphoblastic leukaemia

Eur J Cancer. 2016 Apr:57:87-90. doi: 10.1016/j.ejca.2015.12.031. Epub 2016 Feb 19.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Gene Rearrangement / genetics
  • Humans
  • Infant
  • Infant, Newborn
  • Myeloid-Lymphoid Leukemia Protein / genetics*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality*
  • Prognosis
  • RNA, Messenger / metabolism
  • Translocation, Genetic / genetics
  • Versicans / genetics
  • Versicans / metabolism*

Substances

  • RNA, Messenger
  • VCAN protein, human
  • Versicans
  • Myeloid-Lymphoid Leukemia Protein